IL1B and COVID-19: Another pathological pathway is represented by the dysregulation of the immune system and, because of the activation of endothelial cells and macrophages, a hyperinflammatory phase appears during COVID-19 with the enormous release of TNF-α, IL-1, IL-2, IL-6, IL-8, and chemokines.